A whopping amount of $80 million is secured from an investment in TPG and Temasek by Indian eye hospital chain, Dr. Agarwal’s. This has led to a magnificent rise of 10.3% in its shares. This amount will be really helpful in the expansion blueprint of the company. With a goal to multiply its present network of 150+ centers to 300+ centers in the coming three years. Central and Northern India along with cities like Mumbai will closely witness the expansion, some advanced technological additions will also be made for vision correction and treatment of vitreoretinal diseases. Dr. Agarwal’s group is already a market leader in metro Politian or big cities like Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala, and West Bengal.
This investment from TPG and Temasek will be a game changer for the company, Prof. (Dr.) Amar Agarwal, Chairman of the group is hopeful and confident about this, he expressed the company’s vision of bringing a wave of healthcare excellence around the globe through innovation and cutting-edge technology.
The capital generated will not only be used for expansion in India but also will act as fuel for International expansion, along with the addition of leading-edge technologies. However, the major focus would be on the expansion of the network and establishment of primary eye clinics in tier 2 and tier 3 towns. The group is also considering expansion in Africa, particularly in Kenya, Zambia, and Tanzania.
The company was started in Chennai in the year 1957, supervised by Chairman Prof. (Dr.) Amar Agarwal. It has flourished effortlessly in the Indian market and the profit from the investment will be a stepping-stop towards becoming the global leader in eye care.
